Chang-Hui Xue

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
There is limited knowledge about the metabolic reprogramming induced by cancer therapies and how this contributes to therapeutic resistance. Here we show that although inhibition of PI3K-AKT-mTOR signaling markedly decreased glycolysis and restrained tumor growth, these signaling and metabolic restrictions triggered autophagy, which supplied the metabolites(More)
  • 1